Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Short-term Investments: 2009-2025

Historic Short-term Investments for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $166.8 million.

  • National Healthcare's Short-term Investments rose 121.39% to $166.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.8 million, marking a year-over-year increase of 121.39%. This contributed to the annual value of $140.1 million for FY2024, which is 2605.09% up from last year.
  • As of Q3 2025, National Healthcare's Short-term Investments stood at $166.8 million, which was up 121.39% from $146.6 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Short-term Investments registered a high of $166.8 million during Q3 2025, and its lowest value of $100.8 million during Q4 2022.
  • Its 5-year average for Short-term Investments is $124.9 million, with a median of $118.0 million in 2022.
  • Per our database at Business Quant, National Healthcare's Short-term Investments crashed by 1458.98% in 2023 and then skyrocketed by 6130.69% in 2024.
  • Quarter analysis of 5 years shows National Healthcare's Short-term Investments stood at $113.1 million in 2021, then dropped by 10.89% to $100.8 million in 2022, then rose by 10.25% to $111.1 million in 2023, then increased by 26.05% to $140.1 million in 2024, then increased by 19.06% to $166.8 million in 2025.
  • Its last three reported values are $166.8 million in Q3 2025, $146.6 million for Q2 2025, and $152.8 million during Q1 2025.